Huntsman and Olin Announce All-Stock Merger of Equals to Create $12.5B Chemicals Leader
HUN sits 95% above its 52-week low of $7.295.
Summary
Huntsman and Olin announced an all-stock merger of equals to form OlinHuntsman Corporation, a $12.5 billion chemicals leader, expecting over $400 million in synergies.
Key Events · M&A and Partnerships · HUN
-
Merger of Equals Announced
Huntsman Corporation and Olin Corporation have entered into a definitive agreement for an all-stock merger of equals, forming OlinHuntsman Corporation.
-
Significant Scale and Revenue
The combined company is projected to have approximately $12.5 billion in combined 2025 revenue, creating a leading North American chemicals entity.
-
Substantial Synergies Identified
The merger is expected to generate over $400 million in total identified cost synergies and integration benefits, with the majority realized within 24 months, plus an additional $125 million in cash tax benefits from accelerated Net Operating Losses.
-
Ownership and Leadership Structure
Olin shareholders will own approximately 54.5% and Huntsman shareholders 45.5% of the combined company. Ken Lane (Olin CEO) will serve as CEO, and Peter Huntsman (Huntsman CEO) as non-executive Chairman.
Analysis · HUN · Industrial Applications And Services
Huntsman Corporation and Olin Corporation are combining in an all-stock merger of equals, creating a new entity, OlinHuntsman Corporation, with approximately $12.5 billion in combined 2025 revenue. This transformative transaction aims to enhance scale, improve cost position through vertical integration, and generate over $400 million in annual cost synergies and integration benefits, plus an additional $125 million in cash tax benefits. The deal fundamentally alters Huntsman's business structure and market position, positioning it as a leading North American chemicals company.
At the time of this filing, HUN was trading at $14.25 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $7.30 to $16.09. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.